Crizotinib safe, effective for ALK+ pediatric ALCL, IMTs

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • In children with advanced anaplastic large cell lymphoma (ALCL) and inflammatory myofibroblastic tumors (IMTs), crizotinib (Xalkori) is safe and effective.
Why this matters
  • Advanced ALCL and IMTs have a poor prognosis.
Study design
  • In this phase 2 Children's Oncology Group trial, saf...